Navigation Links
Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness
Date:12/18/2007

he Strategic National Stockpile.

-- Twenty-one states do not have statutes that allow for adequate liability protection for healthcare volunteers during emergencies.

-- Twelve states do not have a disease surveillance system compatible with the Centers for Disease Control and Prevention's (CDC) National Electronic Disease Surveillance System.

-- Seven states have not purchased any portion of their federally-subsidized or unsubsidized antivirals to use during a pandemic flu.

-- Seven states and D.C. lack sufficient capabilities to test for biological threats.

"There is little doubt that emergency health preparedness is on the national radar," Levi added. "But until all states are equally well prepared, our country is not as safe as it can and should be."

The report highlights two areas of particular concern with regard to state-level preparedness:

-- Twenty-one states do not provide sufficient legal protection from liability for healthcare volunteers who respond to a call for assistance in an emergency. Lack of such protections has been identified as a key impediment to recruiting sufficient volunteers to respond to a major health emergency. TFAH recommends that states adopt the Uniform Emergency Volunteer Health Practitioners Act (UEVHPA), which has been approved by the National Conference of Commissioners on Uniform State Laws.

-- Seven states have made no purchases toward their share of the stockpile of antivirals for pandemic influenza. States have been asked to purchase 31 million treatment courses of the 81 million course stockpile target set by the federal government. Containment of a pandemic must be a national priority. Any differences in capacity on a state-by-state basis place the entire nation at risk.

The report also evaluates federal progress in preparing the country for bioterrorism, disasters and disease. TFAH finds that the passage of the Pandemic and All-Hazards Preparedness Ac
'/>"/>

SOURCE Trust for America's Health
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
2. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
3. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
4. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting
6. AQUISS Expands Into Significant New Territory
7. 454 sequencing uncovers significant genetic variation
8. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
9. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
10. Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting
11. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 Clintrax Global, Inc., ... in Raleigh, NC , recently ... as Vice President of Administration. ... all corporate processes, including their alignment with company ... Brad worked as an HR executive, specializing in ...
(Date:8/20/2014)... it that American Indians largely were wiped out by ... tuberculosis brought to the New World by European explorers., ... people lived in the Americas shortly before Europeans arrived, ... European diseases., But new research led by anthropological geneticists ... of the University of Tubingen in Germany indicates the ...
(Date:8/20/2014)... Fla. , Aug. 20, 2014 ... will host a conference call to provide an ... 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. ... 9126599 Live web cast: www.neurotropebioscience.com , under "Investor ... hours after completion through September 2, 2014 at ...
(Date:8/20/2014)... Aug. 20, 2014  Decision Resources Group finds that the vascular ... Russia , India and ... 2013, roughly equal to the size of the United ... market will experience much faster growth as a result of strong ... Other key findings from Decision Resources Group,s coverage of the ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3Neurotrope To Host Conference Call 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3
... -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported ... that supports the broad anti-viral potential of the ... its PS-targeting drug bavituximab can cure lethal virus ... Bavituximab is in clinical trials for the treatment ...
... ILE ) today announced that on March ... "Exchange") notifying the Company it is not in compliance ... "Company Guide"). Specifically, the Exchange staff noted that the ... to its overall operations or its existing financial sources ...
... Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ... I/II U.K. trial of REOLYSIN(R) combined with paclitaxel/carboplatin for ... International Meeting on Replicating Oncolytic Virus Therapeutics. The meeting ... to 22nd, 2009. The principal investigator for the trial ...
Cached Biology Technology:Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections 2Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections 3Isolagen, Inc. Receives Notification Letter from Amex 2Isolagen, Inc. Receives Notification Letter from Amex 3Isolagen, Inc. Receives Notification Letter from Amex 4Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial 3
(Date:8/21/2014)... team of researchers at Louisiana Tech University ... affordable, consumer-grade 3D printers and materials to ... antibacterial and chemotherapeutic compounds for targeted drug ... students and research faculty from Louisiana Tech,s ... to create filament extruders that can make ...
(Date:8/21/2014)... itself resulting in severe abdominal pain, vomiting and systemic ... are diagnosed with the disease resulting in 1000 deaths. ... to intravenous fluid and nutritional support. , Dr ... led the research, said "The major causes of pancreatitis ... alcohol intake combined with a high fat diet. In ...
(Date:8/20/2014)... CITY Researchers at Huntsman Cancer Institute (HCI) at the ... of the gene that encodes BCR-ABL, the unregulated enzyme ... to the American Cancer Society, nearly 6,000 new cases ... already in use, called tyrosine kinase inhibitors (TKIs), target ... do not cure CML but control it in a ...
Breaking Biology News(10 mins):Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3Insulin offers new hope for the treatment of acute pancreatitis 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... symptom of physical pain or stress. But now a ... showing that tears have emotional benefits and can make ... Hasson of TAU,s Department of Zoology shows that tears ... an evolution-based mechanism to bring people closer together. ...
... by climate scientists at the University of East Anglia (UEA) ... field in the last two years. The article, ,Tipping ... Proceedings of the National Academy of Sciences in ... Paper, by Thomson Reuters. "The article captures the zeitgeist ...
... female cells counteract their double dose of X chromosomes by coating ... binds to the same X chromosome from which it is transcribed ... silencing. In the August 24, 2009 issue of the Journal ... the fact that XIST temporarily dissociates from the X chromosome during ...
Cached Biology News:Trust in a teardrop 2Tipping elements remain a 'hot' issue 2Tipping elements remain a 'hot' issue 3Aurora B answers an XIST-ential question 2
UBC13 Antibody...
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Phenytoin-BSA Isolated IgY DFc Drug...
Tropomyosin 4 [Tm4]...
Biology Products: